Between Nov @ , @ , and Nov @ , @ , @ patients were randomly assigned to receive standard-dose chemoradiotherapy , @ to high-dose chemoradiotherapy , @ to standard-dose chemoradiotherapy and cetuximab , and @ to high-dose chemoradiotherapy and cetuximab .